Toxoplasmosis 2017
DOI: 10.5772/intechopen.68235
|View full text |Cite
|
Sign up to set email alerts
|

Microparticle Vaccines Against Toxoplasma gondii

Abstract: Significant information indicates that future investigations on Toxoplasma vaccine development have to include adjuvants for enhancing protective immunity against Toxoplasma gondii. Especially, safe and effective adjuvants capable of fulfilling Th1-dependent cellmediated immunity appear to be more likely to be allowed to use for anti Toxoplasma vaccine development. Recently, biodegradable and biocompatible polymers, such as poly (lactide-co-glycolide) (PLG) polymers, have been utilized as safe and efficacious … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 55 publications
(145 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?